Natco Pharma submits copy of press release

25 Aug 2016 Evaluate

Natco Pharma has submitted a copy of Press Release dated August 25, 2016 titled ‘NATCOs marketing partner Mylan Invalidates Two of Tevas Copaxone 40 mg/mL Patents Via US Patent and Trademark Offices Inter Partes Review Proceeding’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

917.90 3.05 (0.33%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.10
Dr. Reddys Lab 1278.90
Cipla 1517.00
Zydus Lifesciences 919.85
Lupin 2125.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×